Brexanolone Lifting Outcomes Of Moms
Start Date
9/1/2026
Completion Date
9/1/2027
Summary
The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause
Eligibility Criteria
Age Range: 15 years to 45 years
Interventions
LPCN 1154A
Placebo
Conditions
Locations
Lipocine Investigational Site
Tucson, Arizona 85715
United States
Lipocine Investigational Site
Canoga Park, California 91304
United States
Lipocine Investigational Site
Walnut Creek, California 94596
United States
Lipocine Investigational Site
Aurora, Colorado 80045
United States
Lipocine Investigational Site
Decatur, Georgia 30030
United States
Lipocine Investigational Site
Idaho Falls, Idaho 83402
United States
Lipocine Investigational Site
Chicago, Illinois 60641
United States
Lipocine Investigational Site
New Orleans, Louisiana 70115
United States
Lipocine Investigational Site
Las Vegas, Nevada 89119
United States
Lipocine Investigational Site
Princeton, New Jersey 08540
United States
Lipocine Investigational Site
Manhattan, New York 10036
United States
Lipocine Investigational Site
Chapel Hill, North Carolina 27514
United States
Lipocine Investigational Site
Plano, Texas 75093
United States
Lipocine Investigational Site
Richardson, Texas 75080
United States
Lipocine Investigational Site
Clinton, Utah 84105
United States
Lipocine Investigational Site
Orem, Utah 84058
United States